Sphere Fluidics

Sphere Fluidics

Private
Cambridge, EnglandHealthcare & Life Scienceswww.spherefluidics.com

Last Round

Series C

Oct 28, 2021

Total Funding Raised

$51.57M

Company Overview

Sphere Fluidics is a life sciences company that develops innovative technologies for single-cell analysis and therapy development, providing systems that aid in the discovery of new cell strains and molecules while streamlining the screening and isolation of rare biological variants across various applications.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Hardware + Subscription

AI Layer

Non-AI

Keywords

single-cell analysispicodroplet technologyhigh-throughput screeningcell line developmentCLDantibody discoverylab automationbiologics discoverylife science toolsdroplet microfluidicsclone isolationcell therapy developmentassay kitssynthetic biology toolsinstrument and reagent model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sphere Fluidics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Sphere Fluidics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series COct 28, 2021
Series BJun 10, 2019
GrantNov 28, 2017
Series BFeb 15, 2017
VC RoundFeb 10, 2016
Series A
Jun 16, 2014

Sphere Fluidics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 27, 2025

    Presented at SLAS2025 and launched new Cyto-Mine Chroma product.

  • Jan 27, 2025

    Cyto-Mine Chroma launched with an Early Access Program.

Sphere Fluidics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sphere Fluidics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sphere Fluidics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, England
Employee Range23
Year Founded2010
Last FundingOct 28, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.